@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:inhibit . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T19:54:25.224230"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "both tumor necrosis factor" . rdf:OBJECT-POSITION rdfs:label "65"^^xsd:integer . rdf:PREDICATE rdfs:label "inhibited" . rdf:PREDICATE-POSITION rdfs:label "[50]" . rdf:SUBJECT rdfs:label "dexamethasone ( DEX )" . rdf:SUBJECT-POSITION rdfs:label "15"^^xsd:integer . rdfs:ABSTRACT-UID ns2:50 "ewg8q1io" . rdfs:SENTENCE rdfs:label "glycyrrhizin (GL), as well as dexamethasone (DEX) inhibited both tumor necrosis factor (TNF)-α –and IL-1β –induced IL-8 production, mRNA expression, and promoter activity in A549 lung epithelial cells." . rdfs:TRIPLE-UID ns3:ewg8q1io-TRIPLE-ABSTRACT-1 "ewg8q1io-TRIPLE-ABSTRACT-1" . rdfs:label "dex" . rdfs:label "tumor necrosis factor" . } sub:pubInfo { sub:assertion prov:wasDerivedFrom . sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "Kc4Gu2aAhgBNJpDv+GNJDd8iKJ6lhwoOlVMlHI12QFRl3NnE93dlEPvEBKLeCRAO3ZhOFui6RQoNyb7tubKmtZZkzxt1eAGkglESSmR8W7fVMYf1aSCD+GTerNSXsu1yUgPi56RbSMRWSvexyhtlz4vZZLjTb1Sx5mmjnU6iYE8="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T19:54:25.224230"^^xsd:dateTime; prov:wasAttributedTo . }